Clinical Trial Update: Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial of toripalimab in combination with gemcitabine for cisplatin-ineligible locally advanced urothelial carcinoma/bladder cancer has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Carcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Urothelial Carcinoma, Bladder Cancer | Phase 2 | Status: COMPLETED